Max Stock FY26 Q2 GAAP net income rises 30.4% to ILS 35.9 million; revenue increases 12.7% to ILS 379 million
Reuters2026/08/11 04:40- Max Stock posted Q2 GAAP net income up 30.4% to ILS 35.9 million, as revenue rose 12.7% to ILS 379 million.
- Gross margin widened 3.3 percentage points to 47.1%, mainly on a stronger shekel versus the dollar and improved terms of trade.
- Adjusted EBITDA climbed 37.1% to ILS 77.5 million, lifting the adjusted EBITDA margin 3.6 percentage points to 20.4%.
- Comparable store sales increased 7%, driven by higher traffic and a larger average basket on a richer product mix.
- The board declared a one-time dividend of ILS 50 million, or ILS 0.36 per share, payable Sept. 9 to holders of record Aug. 18.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cambria Gold Mines FY26 Q2 net loss narrows to CAD 2.96 million
TRUMP rises nearly 8% in 24 hours, market capitalization reaches $2.037 billions
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
Crypto prices
More
